System for predicting probability of poor ovarian response of subject under antagonist regimen, and system for guiding selection of gonadotropin starting medication dose
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- GUANGZHOU KANGRUN BIOTECHNOLOGY CO LTD
- Publication Date
- 2019-12-13
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The present invention relates to a system for predicting ovarian hyporesponsiveness in a subject under a dosing regimen of an antagonist, and a system for guiding the starting dose range of gonadotropins (Gn). Background technique
[0002] In the process of controlled ovulation induction (COS), the number of retrieved eggs is considered to be a powerful predictor of successful pregnancy after IVF-ET (in vitro fertilization-embryo transfer). A study of more than 400,000 people in Europe published in the authoritative journal "Human Reproduction" showed that compared with a lower number of eggs retrieved on the day of egg retrieval, the appropriate number of eggs retrieved significantly increased the live birth rate. During COS, the main problem faced by patients is the insufficient number of oocytes retrieved, that is, low ovarian response, which leads to high cycle cancellation rate and adverse pregnancy outcomes, such as low embryo implantation rate, ...